TerrAscend Corp (TSNDF)

[nowwhat2]

TerrAscend's UP today (for some unknown reason)






3 trading days ago :






.

[JohnCM]

Jan 15, 2019, 18:01 ET

TORONTO, Jan. 15, 2019 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend") today announced the closing of the previously reported asset acquisition of Grander Distribution, LLC ("Grander"). Grander is an industry leader in the production and distribution of innovative hemp-derived wellness products. Their whole-plant hemp extract products are made in the USA and are available for sale in ~10,000 retail locations worldwide.

About TerrAscend Corp.

TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. TerrAscend provides support to patients and consumers through its wholly-owned subsidiaries, TerrAscend Canada Inc., a licensed producer of cannabis pursuant to the Cannabis Regulations under the Cannabis Act (Canada) that provides medical cannabis to patients through its online medical marketplace Solace Health, and Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals. TerrAscend participates in the legal adult-use market in Canada through direct and indirect supply agreements in several provinces and the US market in states where cannabinoids have been legalized for therapeutic or adult-use. TerrAscend, in partnership with leading researchers Cistron Corp, launched Ascendant Labs, a biotechnology and licensing company committed to the continuous improvement of cannabinoid expressing plants.

[nowwhat2]

Well ?.......So what did U find out ? / What did U learn ?

What did your DD reveal ?

[nowwhat2]

Possibly but this seems really weird :

https://www.prnewswire.com/news-releases/terrascend-completes-acquisition-of-grander-distribution-a-us-hemp-derived-products-company-300778987.html

https://www.grander.com/intl-en/international/collaboration


Lemme know if ya' figure it out ?



"Technically" ? - Purchase as close to this line as possible but as soon as ya' see it going poking below (if it does), then get the heck on out ?






Slight difference - and this is the one I'd be going by

[JohnCM]

Terrascend from $10 US to here. Is this a buy/sell or hold?

[nowwhat2]

Ok...So.....No ; Here ;

Let us consider some facts ! http://bfy.tw/LjUo







Previously : Clonk ! and then TARGET achieved :









Lastly : Previously (even before the above) :









In other words : Sorry to inform you - But these charts are fantastic !







Corporal nw 2019

[nowwhat2]

3 weeks later : (perfect T.A.)

"Patience grasshopper...."





There we are !....Bam !


3 weeks later : (perfect T.A.)




Meanwhile, I dunno much about thems fundamentals.....They look and sound a little weird to me....



I hate it when companies tout their activities as making them as "global leaders"......

[JohnCM]

TerrAscend Enters U.S. Hemp Market with $13 Million Acquisition

December 24, 2018 at 9:51 am
Published by NCV Newswire

TORONTO, Dec. 24, 2018 /PRNewswire/ – TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend”) today announced the signing of a definitive agreement (the “Agreement”) to acquire substantially all of the assets of Grander Distribution, LLC (“Grander” or the “Seller”). Grander is an industry leader in the production and distribution of innovative hemp-derived wellness products.

Their whole-plant hemp extract products are made in the USA and are available for sale in ~10,000 retail locations worldwide. Grander expects 2018 sales to exceed US$10,000,000 with the most recent one month run rate of over US$14,000,000 on an annualized basis. The US$13,000,000 purchase price is an equal combination of cash and stock with the potential for additional consideration of up to US$10,000,000 based on revenue targets of US$35,000,000 in 2019 and US$50,000,000 in 2020. The transaction is expected to close by January 15, 2019, upon completion of standard closing requirements.

"We are thrilled to welcome the Grander team and look forward to leveraging their expansive distribution and branding expertise as we complete the first acquisition of our US strategy. In addition to their seasoned sales force, Grander has a proven track-record of driving the development, manufacturing and processing of innovative hemp-derived cannabinoid products."

Matthew Johnson, President TerrAscend Corp., and TerrAscend USA, Inc.
“With the passing of the 2018 US Farm Bill, and the closing of this transaction, TerrAscend will be well positioned to take advantage of the substantial hemp-derived product opportunity.”

"We couldn’t be more excited to join forces with TerrAscend. The collaboration of talent and expertise across the combined organization will give TerrAscend a significant competitive advantage in developing, marketing, and supplying the most cutting-edge products in the hemp-derived cannabinoid market."

Scott Frohman, CEO of Grander

About TerrAscend Corp.

TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. TerrAscend provides support to patients and consumers through its wholly-owned subsidiaries, TerrAscend Canada Inc., a licensed producer of cannabis pursuant to the Cannabis Regulations under the Cannabis Act (Canada) that provides medical cannabis to patients through its online medical marketplace Solace Health, and Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals. TerrAscend participates in the legal adult-use market in Canada through direct and indirect supply agreements in several provinces and intends to expand into the US market in states where cannabinoids have been legalized for therapeutic or adult-use. TerrAscend also launched Ascendant Labs, a company committed to the continuous improvement of cannabinoid expressing plants, which is a strategic joint venture with leading researchers Cistron Corp.

[JohnCM]

Press Release 12/19/2018

TerrAscend Closes Credit Facility for Up to US$75 Million

PR Newswire

TORONTO, Dec. 19, 2018

Funds immediately available to support TerrAscend's US acquisition strategy

TORONTO, Dec. 19, 2018 /PRNewswire/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend") is pleased to announce that it has finalized the previously announced US$75 million credit facility with certain funds managed by JW Asset Management LLC, where Jason Wild, Chairman of the Board of TerrAscend, is the President and Chief Investment Officer. The credit facility gives TerrAscend access to non-dilutive capital for acquisitions in the United States, as well as for general corporate and working capital purposes. Funds will be immediately available and will bear interest at 8.75% per annum, with a 1% origination fee. Amounts drawn under the facility, which matures on December 19, 2019 will be guaranteed by TerrAscend Corp. and one of its wholly-owned Canadian subsidiaries and will be secured by certain of such subsidiary's inventory and trade receivables.

"Following up on our announcement last week, I am pleased to report that we have fully executed the credit facility with immediate access to those funds. We look forward to sharing more details regarding progress on our US strategy in the coming days and weeks," stated Matthew Johnson, President of TerrAscend Corp. and TerrAscend USA.

[JohnCM]

[nowwhat2]

Patience grasshopper....

This chart from 10 days ago :




It still has a bit further to go !...(compare)

[JohnCM]

GREEN today

Origin House ORHOF
TerrAscend TRSSF

[Jdoggg]

NEWS!! https://www.ftmig.com/cannabis/terrascend-announces-agreement-for-us75-million-credit-facility/

[nowwhat2]

Maybe I'm the one keeping this board "posted" . . . . just via old-fashioned simple T.A.






Will need to remain higher than that low of 3 weeks ago or else the magnet wins !





Might as well just park a bid at 5.50 now (be one of the first in line)....Just for if it does get there.





Just park a bid there and head off to Antigua




Come back to discover that you've timed the thing perfect





Which likely will have paid for the entire vacation / Green fees / Drinks / Hotels, etc.





.

[JohnCM]

I could use a good number.

[nowwhat2]

About to report ?.....Keep us posted. Please Thanks.

[Jdoggg]

NEWS!! https://www.ftmig.com/cannabis/terrascend-announces-third-quarter-2018-financial-results/

[JohnCM]

https://www.youtube.com/embed/2HyqfSiNbps

CEO interview

[JohnCM]

Recent profit taking down to 8 was good for buyers or scary for holders.

[Space Cats]

Looking for entry today or early next week

[JohnCM]

I did not catch the dip. My basis is in the 9's.

[Space Cats]

Helluva ride from late September...

...one I wish I would've been on :)

My Netflix show is: Master of Watching

[JohnCM]

$8.22

Low of day

$7.49

Volatility anyone?

[JohnCM]

TerrAscend Secures Multi-Year Cannabis Supply Agreement with PharmHouse Inc., a Canopy Rivers Joint Venture

BY Canada NewsWire 10/15/2018

TerrAscend Corp. today announced that its subsidiary TerrAscend Canada Inc. (o/a Solace Health) ("TerrAscend Canada") has entered into a multi-year cultivation agreement with PharmHouse Inc. ("PharmHouse"), a joint venture between Canopy Rivers Inc. (TSXV: RIV) ("Canopy Rivers") and the principals and operators of a leading North American greenhouse produce company.

www.TerrAscend.com (CNW Group/TerrAscend)

Under the terms of the agreement, PharmHouse will grow and supply cannabis to TerrAscend Canada from an existing 1.3 million square foot greenhouse ("Facility"), located in Leamington, Ontario. Once fully licensed, the production of flower, trim and clones from 20% of the dedicated flowering space at the Facility will be made available to TerrAscend Canada.

TerrAscend Canada may provide proprietary genetic strains to PharmHouse and help oversee production in conjunction with their operators and quality assurance professionals. Cultivation is anticipated to commence in 2019, subject to receipt by PharmHouse of all applicable regulatory licenses and approvals.

Michael Nashat, President and Chief Executive Officer, stated, "This agreement provides TerrAscend with access to high quality greenhouse grown cannabis and significantly advances our strategy in focusing on the production of premium products and standardized dosage forms, consistent with GMP standards. Partnering with PharmHouse further offers TerrAscend large-scale cultivation expertise and production capabilities."

[JohnCM]

TerrAscend Corp bottom

[JohnCM]

TerrAscend Launches Haven St. Premium Cannabis for Adult Use

BY Canada NewsWire 10/16/2018

TORONTO, Oct. 16, 2018 /CNW/ - TerrAscend Corp. today announced the unveiling of Haven Street ("Haven St."), a premium cannabis brand for the Canadian adult-use market that will launch nationally on October 17, 2018 with 48 unique SKUs in dry flower and pre-roll forms.

www.havenst.ca (CNW Group/TerrAscend)

Upon launch, the Haven St. brand will consist of twelve strains and multiple formats ranging from single and 5-pack pre-rolls to 1g and 30g dry flower formats.

Positioned for the premium segment of the market, Haven St. was inspired by the welcoming nature of a neighborhood that invites exploration and encourages new experiences. TerrAscend conducted extensive consumer research to develop the Haven St. suite of products targeting adult consumers who enjoy cannabis, value variety and seek premium experiences.

The dry flower and pre-roll selections of Haven St. are designed to appeal to consumers who are loyal to a trusted, quality brand that offers multiple options for their varied moods or occasions. The strain offerings are segmented by five consumer need states: Peace, Reset, Focus, Drift and Rise.

"We have taken a consumer-centric approach to developing the Haven St. brand while ensuring we deliver a mature, premium experience across all aspects of the consumer journey," said Keith Gillespie, TerrAscend's Adult Use, VP of Marketing.

"We believe our premium quality Haven St. products will offer a distinctive brand that consumers can trust, ensure recognition at the point of sale, and will enable us to differentiate ourselves in the emerging adult-use cannabis market. Our unique street-like address system that ranges from 100 - 500 and categorizes our products from low THC to high THC creates a simple way for adults to explore our cannabis offering. Within the Haven St. neighborhood, every address leads to a new experience. Wherever you're going, Haven St. can take you there," added Gillespie.

Haven St. has secured coast-to-coast distribution in the legal adult-use channel spanning BC, Ontario, Nova Scotia and PEI, and is currently fulfilling initial purchase orders from the provinces. Distribution for additional provinces is planned before the end of 2018. Haven St. has been named a participant in the first ever AHLOT Cannabis Collections™ Discovery Series Vol.1™, which brings together five different licensed producers into a single experiential consumer offering.

For more information about Haven St., please visit us at: www.havenst.ca or on Social Media as follows:

Linkedin: HavenStreet
Twitter: ExploreHavenSt
Facebook: ExploreHavenSt
Instagram: ExploreHavenSt
YouTube: Explore Haven St

About TerrAscend Corp.

Is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. On October 9, 2018, TerrAscend ( TRSSF ) announced its intentions to expand into the US market. The Company provides support to patients and consumers through its wholly-owned subsidiaries, TerrAscend Canada Inc., o/a Solace Health, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals and Solace Health, the online marketplace for the licensed producer. The Company will also participate in the adult-use market in Canada following legalization through direct and indirect supply agreements in several provinces. The Company holds a partnership with leading researchers in Ascendant Labs, a cannabis biotechnology and licensing company committed to the continuous improvement of the cannabis plant.

[JohnCM]

Shares Outstanding 94.44M

[JohnCM]

I had to get on board. Based solely on chart activity.

[JohnCM]

TerrAscend is on a huge tear. O/S?

[JohnCM]

Added 900 shares ...

[MobiusX]

there *might* not be any bag holders for this one with recreational being legalized in 3 days. Wait till the sheep start to figure it out.

I expect there will be many pothead millionaires made because they have lived under the persecution for the last 70 years of a multi trillion dollar war on drugs, seen the devastation of wrong laws first hand, understand the REAL value of the "grower" and "vertical" pot company stocks are unlike all the other 10k stocks out there.

This is a global rennasaince in law and social justice. Its not "just another company stock".

just IMO.

[Deehrm29]

I am waiting prob wrong but won't be a bag holder

[craig2558]

I through a grand at the stock at $2 because it wasn’t far from my house and my buddy gave me a tip. I’ve been smiling ever since. So quiet but just keeps going up.

[Space Cats]

Not sure why either

All I've done is watch it soar over the past three weeks.

Having a hard time pulling the trigger for that reason.

Literally my loss for not doing so.

Almost $2 million in dollar volume yesterday, which I think is the biggest yet. Something is definitely up.

Might finally jump in for a few tomorrow.

[craig2558]

I know they are connected with CGC so that’s def a good thing. But I ask myself the same thing. So under the radar. No one is talking about this stock

[Deehrm29]

How does this keep going up? No revs and all others go down

[craig2558]

Anyone here?

[JohnCM]

If you have nothing better to do, I think you will enjoy this presentation. I found it interesting.

I can see why Namaste and IBM hit it off at the Retail Global 2018. This is a long video but interesting if you have time.

[Dbrown13]

Yeah you know, shady. I’m still not convinced.

[JohnCM]

Shady??

[JohnCM]

TerrAscend Partners with Cistron to Advance Cannabis Genetics

June 7, 2018 at 8:14 am
Published by NCV Newswire

TerrAscend and Cistron Launch Ascendant Laboratories

TORONTO, June 7, 2018 /CNW/ – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) is pleased to announce the formation of a strategic joint venture with Cistron Corp. (“Cistron”) with the launch of Ascendant Laboratories Inc. (“Ascendant Laboratories”), a science and innovation company dedicated to the advancement of cannabinoid expressing plant biology. Ascendant Laboratories brings together leaders in plant sciences and cannabis production, with a unified vision of elevating the cannabis industry through the development of advanced plant genetics.

Transaction Details

Cistron has agreed to grant to Ascendant Laboratories an exclusive license over proprietary intellectual property rights and trade secrets relating to cannabis plant and plant-derived cannabinoid research, and TerrAscend has agreed to contribute cash payments of up to C$1,250,000 in return for a combination of shares and warrants, representing approximately 75% of Ascendant Laboratories on a fully-diluted basis. The transaction is valued at approximately C$1.7 million.

TerrAscend is thrilled to be partnering with Cistron and its team of accomplished scientists. As a company with a major research and development mandate, TerrAscend is looking forward to adding substantial depth to our science team through this partnership with Cistron and its principals. Ascendant Laboratories will be leveraging the knowledge and experience that Cistron has developed in plant sciences and applying it to improve plant yield, add diversity, promote immunity, and modify the physical and chemical traits of cannabinoid expressing plants.

Michael Nashat, TerrAscend’s President and Chief Executive Officer
Cistron’s co-founding scientists Dr. Peter McCourt, Dr. Shelley Lumba and Dr. Dario Bonetta will lead the cannabis science and discovery programs at Ascendant Laboratories. Dr. Peter Azmi, will be appointed Ascendant Laboratories founding President and Chief Innovation Strategist.

Dr. Peter McCourt is a Professor in the Department of Cell & Systems Biology at the University of Toronto and is a world recognized authority on functional genomics, systems biology and plant bioengineering. Dr. McCourt holds a PhD from Michigan State University and is presently a Jack Dainty Distinguished University Professor. He has published over 100 peer-reviewed publications and holds several patents related to abiotic stress genes in plants.

Dr. Shelley Lumba is a leading expert in plant biology, systems biology and plant biotechnology. Dr. Lumba holds a PhD from the University of Toronto and is an Assistant Professor in the Department of Cell and Systems Biology at the University of Toronto.

Dr. Dario Bonetta is a biotechnologist with extensive experience in plant transformation, in vitro plant systems and plant biotechnology. Dr. Bonetta holds a PhD from the University of Toronto and is an Associate Professor in the Department of Biology at the University of Ontario Institute of Technology.

Dr. Peter Azmi is a business innovation and biotechnology specialist and has worked extensively in the life sciences and biotechnology sectors. Dr. Azmi holds a Masters and PhD from the University of Toronto and is a visiting professor of Business Innovation at CEDIM.

Dr. Peter McCourt, President of Cistron, noted “This will be a novel endeavour that brings together the cutting-edge molecular plant biology innovation of Cistron with the leadership experience in cannabis production of TerrAscend. We look forward to developing and bringing to market exciting new technologies that will help support wellness and the future growth and prosperity of this industry.”

We are excited to be partnered with TerrAscend on this bold venture. Our shared vision for Ascendant Laboratories is to become a global leader and resource for cannabis plant sciences and innovation.

Dr. Peter Azmi, Cistron Executive Director of Business Development
About TerrAscend

TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licenced producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Terra Health Network Inc., a clinical support program and education platform led by healthcare professionals.

About Cistron Corp.

Cistron is an agricultural biotechnology and contract research firm that helps commercial growers develop the next generation of cash crops and plant-based biotechnologies. Cistron helps growers by providing deep bio-analytical insights into plant biology, which can be used to develop purpose-built plants and secure investments in intellectual property.

[Dbrown13]

Dollinger does not make my list. I didn’t really like the early namaste. Seemed shady.

[JohnCM]

Looking for one more great MJ play.

On Monday I will have

NMUS
MPX
NAMASTE

I cannot buy HIKU

not DTC eligible

[Dbrown13]

Oh look! A place where you can post anything! Audience Schmaudience :)

[JohnCM]

5 Canadian Cannabis Updates That Impacted Shares

March 8, 2018

The Canadian cannabis sector recently came off its highs and investors are closely monitoring the recent pullback. Prior to this weakness, Canadian cannabis stocks were in rally mode and we remain bullish on these moves.

Over the last week, several significant company announcements have been reported and today, we have highlighted five important company updates that cannabis investors need to be aware of.

MPX: Increases Market Share in the United States

MPX Bioceutical (MPX.CN) (MPXEF) has fallen more than 15% from its February highs and we are monitoring the recent decline. We have been bullish on MPX and continue to see upside to current levels as the company continues to execute flawlessly on growth initiatives.

Earlier this week, MPX’s subsidiary, CGX Life Sciences, expanded its reach in Arizona after entering a definitive limited liability membership interest and asset purchase agreement to acquire 100% of ABACA, LLC, Ambary, LLC, Tarmac Manufacturing, LLC, and Tower Management Holdings, LLC.

ABACA is a fully-integrated medical marijuana business licensed in Arizona that operates a dispensary under the name The Holistic Center in Phoenix, Arizona as well as certain real estate interests located in Phoenix. Today, MPX will hold an investor call at 10am EST to discuss this acquisition and MPX’s third quarter results.

In return for the acquisition, MPX is paying $15,000,000 in cash and stock ($12 million cash). The company will issue $3 million worth of stock (5,704,479 common shares) and 4,700,000 common share purchase warrants (at $0.67 for five years). In addition, CGX has a contingent liability of up to $6,000,000 payable to the sellers solely out of the proceeds of the revenue generated from the contract between Tarmac and Timeless Select, LLC.

MPX is laser focused on several emerging legal marijuana markets in the United States and we are bullish on this focus. Although the shares have come off its highs, they are still up a considerable amount in the last six-months (up 128%). We are monitoring the recent decline and believe it has created a great opportunity for new investors. This is a stock to watch!

Maricann: Takes Investors for a Ride

Maricann Group Inc. (MARI.CN) (MRRCF) has taken investors on a roller-coaster ride in the last week and has recaptured all of its losses from last week.

This volatility comes after the Canadian marijuana producer received a notice of termination from Eight Capital, Canaccord Genuity Corp., GMP Securities L.P., Industrial Alliance Securities Inc. and Clarus Securities Inc., regarding the previously announced $70 million private placement.

The weakness came after the Ontario Securities Commission (OSC) said it is conducting a review of the timing and reporting of certain trades in securities of the company beneficially owned, directly or indirectly, or over which control or direction is exercised by Messrs. The OSC also said that Maricann CEO Ben Ward is the subject of an investigation into his activities while he was CEO of Canadian Cannabis Corp., a company wholly unrelated to the company.

While these reports are concerning, we continued to hold Maricann and are very glad that we did. When these reports surfaced, Maricann dropped approx. 20% and we are monitoring how this story develops.

Hiku Brands: Continues to Execute on Growth Initiatives

Hiku Brands Company Ltd. (HIKU.CN) (DJACF) rallied off its morning lows and this comes after the company issued an update on recent corporate development initiatives. We are favorable on this update and remain bullish on Hiku due to the funded growth initiatives, the strategic relationship with Aphria, and the continued execution.

Hiku Brands was formed after DOJA Cannabis and Tokyo Smoke completed a merger and we are favorable on the combined company. Yesterday, Hiku announced that its subsidiary, DOJA Cannabis (a licensed cannabis producer under the ACMPR), submitted its application to produce medical cannabis oils at its second site facility.

Hiku also announced that it signed a strategic partnership agreement with Vitalis Extraction Technology, whereby Vitalis will advise on the build-out of the extraction lab, partner on certain research and development initiatives, and supply the facility with Vitalis' Q-90 supercritical CO2 extraction system - which is capable of processing up to 80 kg of cannabis flower per day.

We are bullish on these announcements and are favorable on the focus on the cannabis oil opportunity. We continue to believe that the trend towards smokeless products will become more pronounced and are favorable on this growth initiative. Hiku offers cannabis investors a differentiated opportunity that is levered to Canada’s recreational market and we are bullish.

Organigram: Focused on International Markets

Organigram Holdings Inc. (OGI.V) (OGRMF) is laser focused on expanding into new international markets and capitalizing on these new emerging opportunities. From Germany to Australia, Colombia to Israel, the legal cannabis market continues to expand as countries continue to hop on the legal cannabis bandwagon and we are very favorable on this trend.

Yesterday, Organigram appointed Guillermo Delmonte as the President of its new international division. Delmonte joins the Organigram team after serving as CEO of ICC Labs Inc. (ICC:APH) (ICCLF), a leading international hemp and cannabis producer. In this role, he successfully oversaw the ICC's initial public offering (IPO) as the first South American cannabis company to go public with a first day valuation of more than $120 million CAD.

As President of this new venture, Delmonte will lead the planning and execution of the international expansion strategy and work out of multiple locations on behalf of the company. We are bullish on this addition due to the proven track record while CEO of ICC Labs and will keep an eye on how the shares continue to move.

Earlier this week, Organigram received an upgrade from Canaccord Genuity, which raised its price target to $5.50 from $5.25. We remain favorable on Organigram due to the strategic supply agreements with provinces for recreational cannabis, the significantly stronger balance sheet, the improving fundamentals, and the valuation.

Invictus: Announces a Major Milestone

Earlier this week, Invictus MD Strategies (IMH.V) (IVITF) announced a major milestone after closing the acquisition of land and a building for $5.2 million as part of its Phase 2 expansion. The address of the property has been consolidated with AB Labs existing address to allow the existing cultivation and sales license to extend to the property.

The Phase 2 construction adds 40,000 square feet to AB Labs existing 15,600 square feet of cultivation space and is on track for a mid-2018 completion. At the same time, construction planning moves ahead at AB Ventures, located on a 100-acre property near Hamilton. The building team at AB Ventures is now completing all conditions required by the municipality, including a hydrological survey. Immediately following the completion of all of the required documentation, AB Ventures will submit building permit requests.

Once AB Ventures receives its ACMPR license, the entire property will have the potential for cannabis cultivation. Invictus has committed $5.5 million in funding to build out the first 21,000 square foot building on property.

The milestone allows AB Labs to continue moving ahead with its aggressive cannabis production capacity, as Canada marches towards full legalization during 2018. We are favorable on this development and remain bullish on Invictus. We continue to view the company as an acquisition candidate due to the attractive valuation and funded growth initiatives. This is cannabis stock investors need to watch.

[Dbrown13]

It’s Canopys pet. That counts.

[JohnCM]

I don't see the lofty valuation here.

[Dbrown13]

Nice! I did not know that terrascend was First Nations aligned. I couldn’t get the .com link to work. Might be me.

[JohnCM]

Done ...

[JohnCM]

Trying to get chart activated.